European Tissue Processing Systems Industry to 2027 – Rising Number of Diagnostic Laboratories is Driving Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Europe Tissue Processing Systems Market Forecast to 2027 – COVID-19 Impact and Regional Analysis By Product; Volume; End user; and Country” report has been added to ResearchAndMarkets.com’s offering.
According to this report the European tissue processing systems market is expected to reach US$ 123.49 million in 2027 from US$ 87.74 million in 2019. The market is estimated to grow with a CAGR of 4.5% from 2020 to 2027. The report highlights trends prevailing in the Europe tissue processing systems market and the factors driving market along with those that act as hindrances.
By product, is segmented into tissue transfer processors and fluid transfer processors. The fluid transfer processors segment held the largest share of the market in 2019, whereas the tissue transfer processors segment is anticipated to register the highest CAGR in the market during the forecast period. Tissue processing involves preparing tissues for microscopic analysis by putting them in a tangible medium. It helps provide skinny and high-quality slices that can be mounted on the glass slides and properly stained to indicate normal and abnormal structures. Tissue processing systems are widely used in cancer diagnostic laboratories, where biopsy samples are processed for cancer diagnosis. The growing aging population, prone to chronic diseases such as cancer, drives the demand for regular diagnostic tests. As per estimates by Cancer Research UK, there were ~367,000 new cancer cases in the UK in 2017, i.e., ~1,000 cases were reported every day. Thus, increasing prevalence of cancer is likely to boost the demand for tissue processors to perform cancer diagnosis in the coming years. Moreover, the growing network of diagnostic laboratories across Europe is favoring the market growth.
The growth of the Europe tissue processing systems market is attributed to key driving factors such as rising prevalence of cancer and increasing number of diagnostic laboratories across globe. However, high cost of cancer diagnostics is expected to restrict the market growth during the forecast period.
Reasons to Buy
- Determine prospective investment areas based on a detailed trend analysis of the Europe tissue processing systems market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the Europe tissue processing systems market , providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Europe tissue processing systems market.
Market Dynamics
Drivers
- Increasing Prevalence of Cancer
- Rising Number of Diagnostic Laboratories
Restraints
- High Cost of Cancer Diagnostics
Opportunities
- Emerging Markets in Europe
Future Trends
- Development and Launch of Innovative Products
Companies Mentioned
- Miltenyi Biotec
- BioGenex
- Leica Biosystems Nussloch GmbH (Danaher)
- Avantor, Inc.
- THERMO FISHER SCIENTIFIC INC.
- Siemens AG
- F. HOFFMANN-LA ROCHE LTD
- Agilent Technologies, Inc
- Milestone Medical
For more information about this report visit https://www.researchandmarkets.com/r/tn1pe1
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
